Objectives To estimate how many people object to storage of biological samples collected in health care in Sweden and to their use in research and how many withdraw previous consent. Design Cross sectional study of register data.
INTRODUCTION
Erosion of trust [1] [2] [3] in health care and medical science could have severe consequences for medical research. [4] [5] [6] Some studies, however, do not support these concerns. 4 7-10 A recent overview of international surveys found that at least 80% of people are willing to donate biological material for research. 11 Willingness might be even higher in Sweden. [12] [13] [14] Most Swedes seem to prefer general, one time consent in this context. 5 15 People might be less concerned in their daily life about risks entailed by biobank research than they claim to be in surveys.
We determined the extent to which Swedish patients refused consent to storage or restricted the use of samples taken in public health care in 2005 and 2006; whether this poses an actual threat to biobank research; and whether trust in biobank research associated with Swedish health care is eroding.
METHODS
Our targets were biobanks used in health care across the country. We did not include biobanks used exclusively for research or material from blood donations, autopsies, and fetal and infant screening.
Patients can express preliminary refusal to consent either when samples are taken or later by contacting the county's biobank coordinator. In either case, refusalmust be confirmed by submitting a "dissent form" specifying the nature of the refusal (to storage, research, or some particular use). We asked biobank registers across the country for data on confirmed refusal toconsentand the number of laboratory referrals, which is equal to or less than the number of samples, in 2005 and 2006. We obtained full data for 13 of 21 counties, and partial coverage for seven; one county was unable to comply with the request.
Data were separated into series by sample type (for example, histopathological biopsies and cervical screening smears) and geographical location. Variables were expressed as percentages of the number of referrals. For each calculation, we excluded those and only those sample series for which the numerator was missing. We detected changes in overall ratios over time with χ 2 test with continuity correction. We did not test for differencesseries by series, because they varied almost 700-fold in size. 
DISCUSSION
Fewer than 700 in one million Swedes actively oppose storage of or research using biobank samples collected in routine health care. Most of them refuse consent to storage, which is consistent with previous findings that privacy is important whereas the purpose of research is a lesser concern.
11 15 16 The threat posed to quality of research is arguably minimal.
We believe that our results, although not necessarily generalisable to other contexts or cultures, are Region and year representative of patients in Sweden. The geographic coverage was sufficient. The age distribution might be skewed as elderly people are more frequent consumers of health care. Even among young to middle aged women in the cervical screening subgroup, however, the rates of refusal to consent were only about 0.1%. One concern has been that refusal to consentcould be underestimated if several samples requiring separate referrals are taken in one session but the patient submits only one form to cover them all. While such a distortion might affect serological examinations, it is probably less pronounced for the other sample types.
Many people are unfamiliar with biobanks and might be underinformed about their rights and the possible implications of storing biological material. Still, people are becoming increasingly well informed through other channels, such as television, newspapers, the internet, and posters in waiting rooms. If people were concerned about their samples, we would expect more of them to refuse consent over time. Because of the short time frame our results do not exclude the possibility of such a trend, but neither do they support it.
Trust in health care and research While our results tell us what patients do, they may indicate little of what they think. Surveys based on hypothetical situations, though with problems of their own, 17 18 might provide more reliable measures of trust. On the other hand, if we believe that there is a connection between attitudes of trust and trusting behaviour, and, more particularly, assuming that most people with deeply felt distrust will not, given the choice, place trust, 19 our results give us no reason to believe that distrust is widespread.
A complex and costly administration has been set up to protect the small minority of patients who do not want their samples to be stored in biobanks or used in research. The right to say "no" might be justified, no matter how small the minority utilising it, 20 but the means chosen to protect it seem flawed. A system that consumes resources from public health care 21 and imposes a bureaucracy with no benefits, while possibly still failing to inform people of their rights, is not likely to evoke the trust so urgently needed. 22 Though informed consent in biobank research is a complex issue 23 that warrants further research, the present study gives some reasons to consider an alternative system, where consent would be presumed, information readily available, and opting out straightforward. 
